Skip to content

Thoratec

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2024

    FDA issues Class I recall for Abbott HeartMate pumps

    Recall announced

    The FDA issued its most serious recall for Abbott subsidiary Thoratec's HeartMate II and HeartMate 3 pumps, affecting nearly 14,000 devices. The devices can develop a buildup of biological material that reduces blood-flow capability; the article reports that the recall was linked by the agency to hundreds of injuries and at least 14 deaths.

    Company response

    • Ongoing disclosure — Abbott

      In a written response, Abbott said it had communicated the risk to customers this year.

    Source excerpt

    • A pair of heart devices manufactured by a subsidiary of North Chicago-based Abbott Laboratories has received the FDA’s most serious recall after being linked to hundreds of injuries and at least 14 deaths, the agency has announced.
    • According to the FDA’s recall notice, the devices can cause buildup of “biological material” that reduces their ability to help the heart circulate blood and keep patients alive.
    • The recall affects nearly 14,000 devices.